세계의 정신과 의사 시장 보고서(2025년)
Psychiatrists Global Market Report 2025
상품코드 : 1824549
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

정신과 의사 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.5%로 2,770억 7,000만 달러로 성장할 것입니다. 예측 기간의 성장은 원격지 정신건강 서비스 증가, 직장 내 정신건강 대책 증가, 정신건강 보험 적용 확대, 일차 진료와의 통합, 예방 및 조기 개입의 중요성 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 맞춤형 치료 계획, AI와 데이터 분석의 통합, 온라인 지원 커뮤니티, 아동청소년 정신의학에 대한 집중, 원격 모니터링 도구 등이 있습니다.

향후 5년간 6.5%의 성장률 전망은 지난번 전망치보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 이스라엘과 독일에서 공급되는 경두개 자기자극(TMS) 장비의 비용을 상승시킴으로써 미국을 저해하고, 이로 인해 첨단 우울증 치료에 대한 접근성을 떨어뜨리고, 정신건강 서비스 비용을 상승시킬 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

정신보건 개혁에 대한 정부 지원의 증가는 향후 정신과 의사 시장의 성장을 촉진할 것으로 예상됩니다. 이러한 정신건강 자원에 대한 지원은 정신건강 서비스에 대한 수요 증가로 이어져 정신과 의사 시장을 견인하고 있습니다. 예를 들어, 2022년 미국 국립정신건강연구소(National Institution of Mental Health)는 활동성 정신질환(AMI)을 앓고 있는 성인 5,930만 명 중 3,000만 명(50.6%)이 지난 1년 이내에 정신과 치료를 받았다고 보고했습니다. 정신건강 치료를 받았다고 보고했습니다. 이와 같이 정신보건 개혁에 대한 정부의 적극적인 지원은 정신과 의사 시장의 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

제36장 부록

KSM
영문 목차

영문목차

Psychiatrists play a crucial role in diagnosing, treating, and preventing mental, emotional, and behavioral disorders. These licensed practitioners hold either an M.D. (Doctor of Medicine) or D.O. (Doctor of Osteopathic Medicine) degree, and they provide comprehensive care for psychosomatic disorders, mental health issues, and other related conditions. Psychiatrists may establish private or group practices, operating from their own offices, centers, or clinics, or they may work within the facilities of others, such as hospitals or health maintenance organizations (HMO) medical centers.

The main categories of mental disorders addressed by psychiatrists include alcohol abuse mental and behavioral disorders, psychoactive substance use-related mental and behavioral disorders, schizophrenia, schizotypal and delusional disorders, mood disorders (including anxiety and depression), and various other mental and behavioral disorders. Patients seeking psychiatric care can be classified as either inpatient or outpatient, while the approaches employed by psychiatrists may fall under psychological types such as social, abnormal, biological, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The psychiatrists market research report is one of a series of new reports from The Business Research Company that provides psychiatrists market statistics, including psychiatrists industry global market size, regional shares, competitors with a psychiatrists market share, detailed psychiatrists market segments, market trends and opportunities, and any further data you may need to thrive in the psychiatrists industry. This psychiatrists market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The psychiatrists market size has grown rapidly in recent years. It will grow from $195.22 billion in 2024 to $215.02 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to mental health awareness, reducing stigma, policy and insurance support, changing lifestyles, advancements in treatment approaches.

The psychiatrists market size is expected to see strong growth in the next few years. It will grow to $277.07 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rising remote mental health services, rising workplace mental health initiatives, expanded mental health coverage, integration with primary care, focus on prevention and early intervention. Major trends in the forecast period include personalized treatment plans, integration of ai and data analytics, online support communities, focus on child and adolescent psychiatry, remote monitoring tools.

The forecast of 6.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of transcranial magnetic stimulation (TMS) devices sourced from Israel and Germany, thereby reducing access to advanced depression treatments and elevating mental health service costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing government support for mental health reforms is anticipated to drive the growth of the psychiatrist market in the future. This support for mental health resources has led to a heightened demand for mental care services, thereby boosting the psychiatrist market. For example, in 2022, the National Institution of Mental Health, a US-based research organization, reported that among the 59.3 million adults experiencing an Active Mental Illness (AMI), 30.0 million (50.6%) received mental health treatment within the past year. Thus, the rising government backing for mental health reforms is propelling the growth of the psychiatrist market.

The escalating prevalence of mental illnesses is anticipated to contribute to the growth of the psychiatrist market. Mental illnesses, encompassing a range of conditions affecting cognitive, emotional, and behavioral well-being, pose challenges to daily functioning. Psychiatrists play a crucial role in diagnosing and treating mental illnesses through interviews, psychological tests, and sometimes physical examinations to understand symptoms, medical history, and personal circumstances. A survey by the National Health Service in November 2022 revealed that around 18.0% of children aged 7 to 16 and 22.0% of young individuals aged 17 to 24 exhibited potential mental disorders. Among those aged 17 to 19, the prevalence of probable mental disorders increased from 17.4% in 2021 to 25.7% in 2022. The study involved 2,866 children and young individuals. Therefore, the rising prevalence of mental illnesses is a driving force behind the growth of the psychiatrist market.

A noteworthy trend gaining popularity in the psychiatrist market is the exploration of psychiatric genetics to understand complex disorders associated with mental health. Psychiatric genetics investigates the genetic factors contributing to mental health issues, offering insights to enhance treatment approaches. An example is the discovery of genetic links to anorexia, an eating disorder, where researchers found that metabolic issues were a driving factor. By comparing the DNA of nearly 17,000 individuals with anorexia symptoms to over 55,000 healthy controls, the study identified eight genes linking anorexia to anxiety, depression, and obsessive-compulsive disorder. These genetic insights hold promise for understanding major mental disorders.

Major companies in the psychiatrist market are innovating by developing products such as mental disorder screening tools to cater to larger audiences, drive sales, and increase revenue. Mental disorder screening tools are standardized instruments designed to assess and identify potential mental health issues or disorders in individuals. In May 2023, the American Psychiatric Association (APA) partnered with AvoMD, a US-based software company, to launch an interactive screening and assessment tool for eating disorders. This tool, available at no cost through the electronic health record (EHR), the APA website, and the AvoMD mobile app, guides clinicians in screening, assessing, diagnosing, and planning treatment for individuals with eating disorders. Tailored for various healthcare professionals, including pediatricians, family physicians, and mental health clinicians, the tool features comprehensive evaluation and treatment management strategies, covering screening tools, levels of care, nutrition, exercise, psychotherapy, and more. The tool is accessible on both desktop and mobile platforms, with EHR integration options, facilitating easy documentation by providing a summary of assessment responses.

Major companies operating in the psychiatrists market include Massachusetts General Hospital, Mayo Clinic, Universal Health Services Inc., NewYork-Presbyterian University Hospital of Columbia and Cornell, Johns Hopkins Hospital, McLean Hospital, National Center for Neurology and Psychiatry (NCNP), Wenzhou Kangning Hospital, National Institute of Mental Health and Neurosciences (NIMHANS), East London Health and Social Care Partnership NHS Trust, Bethel Foundation, Department of Mental Health and Neurosciences, Vidyasagar Institute of Mental Health and Neurosciences, Central Institute of Psychiatry (CIP), Institute of Behaviour and Allied Sciences (IBAS), The University of Tokyo Hospital, Baillie Henderson Hospital, Graylands Hospital, Seiwa Hospital, Tokyo Metropolitan Matsuzawa Hospital, The University of Tokyo Hospital, Tokyo Saiseikai Central Hospital, St. Luke's International Hospital, Nightingale Hospital, Tyne and Wear Hospitals NHS Foundation Trust, Forest Independent Hospital, Max Planck Institute of Psychiatry (MPI-P), Spitalul Clinic de Psihiatrie 'Dr. Gheorghe Preda', Psychiatricka klinika 1. LF UK a VFN, National Health Service (NHS), Kursk Clinical Psychiatric Hospital, Menninger Clinic, Sheppard Pratt Health System, Resnick Neuropsychiatric Hospital at UCLA, Centre for Addiction and Mental Health (CAMH), The Royal Hospital for Neuro-disability, Hospital Aleman, Hospital Britanico, Al Zahra Hospital, Al Amal Psychiatric Complex, King Faisal Specialist Hospital and Research Centre, Hunterscraig Psychiatric Clinic, Kirkwood Sanatorium, Dr. F Mohomed, Denmar Specialist Psychiatrist Hospital PTY. Ltd., Umzimzulu Hospital

North America was the largest region in the Psychiatrists market in 2024. The regions covered in the psychiatrists market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the psychiatrists market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The psychiatrists market includes revenues earned by entities by providing psychiatrist services such as mental disorder treatments, anxiety disorders treatments, depression treatments, disruptive behavior and dissocial disorders treatments, and neurodevelopmental disorders treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Psychiatrists Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on psychiatrists market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for psychiatrists ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The psychiatrists market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Psychiatrists Market Characteristics

3. Psychiatrists Market Trends And Strategies

4. Psychiatrists Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Psychiatrists Growth Analysis And Strategic Analysis Framework

6. Psychiatrists Market Segmentation

7. Psychiatrists Market Regional And Country Analysis

8. Asia-Pacific Psychiatrists Market

9. China Psychiatrists Market

10. India Psychiatrists Market

11. Japan Psychiatrists Market

12. Australia Psychiatrists Market

13. Indonesia Psychiatrists Market

14. South Korea Psychiatrists Market

15. Western Europe Psychiatrists Market

16. UK Psychiatrists Market

17. Germany Psychiatrists Market

18. France Psychiatrists Market

19. Italy Psychiatrists Market

20. Spain Psychiatrists Market

21. Eastern Europe Psychiatrists Market

22. Russia Psychiatrists Market

23. North America Psychiatrists Market

24. USA Psychiatrists Market

25. Canada Psychiatrists Market

26. South America Psychiatrists Market

27. Brazil Psychiatrists Market

28. Middle East Psychiatrists Market

29. Africa Psychiatrists Market

30. Psychiatrists Market Competitive Landscape And Company Profiles

31. Psychiatrists Market Other Major And Innovative Companies

32. Global Psychiatrists Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Psychiatrists Market

34. Recent Developments In The Psychiatrists Market

35. Psychiatrists Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기